MRK — Merck & Co., Inc.

—
NYSE · Health Care · Pharmaceuticals · CIK 310158 ·
Last close
$145.31
Market Cap
$358.50B
52W High
$156.00
52W Low
$79.67
ADV30
11,158,607
Next earnings
2026-10-29

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — — — —
Mar 2026 16,286,000,000 12,091,000,000 -3,201,000,000 -4,240,000,000 128,685,000,000 5,327,000,000 82,754,000,000
Dec 2025 16,400,000,000 10,849,000,000 4,065,000,000 2,963,000,000 136,866,000,000 14,565,000,000 84,204,000,000
Sep 2025 17,276,000,000 13,421,000,000 6,554,000,000 5,785,000,000 129,546,000,000 18,169,000,000 77,639,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$17,890,000,000
Investing CF
$-22,464,000,000
Financing CF
$852,000,000
CapEx
$-3,775,000,000
Dividends Paid
$-8,231,000,000
Buybacks
$-4,794,000,000
EPS Diluted TTM
$1.25
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$66,721,000,000
Inventory
$6,479,000,000
Receivables
$12,210,000,000
ST Investments
$375,000,000
EBIT TTM
$13,152,000,000
Pretax Income TTM
$11,630,000,000
Interest Exp TTM
$1,522,000,000
Analysts
26

Yahoo Snapshot (yfinance, live)

Total Revenue
$66,568,998,912
EBITDA
$28,871,000,064
Free Cash Flow
$15,171,500,032
Enterprise Value
$401,921,015,808
Total Cash
$7,141,000,192
Total Debt
$53,910,999,040
Shares Out
2,467,171,638
Trailing EPS
$1.25
Book Value
$16.99
ROE
7.0%
ROA
11.9%
Div Yield
2.36%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 65,011,000,000 22,107,000,000 18,254,000,000 136,866,000,000 84,204,000,000 52,606,000,000 16,472,000,000
Dec 2024 64,168,000,000 20,221,000,000 17,117,000,000 117,106,000,000 70,734,000,000 46,313,000,000 21,468,000,000
Dec 2023 60,115,000,000 2,954,000,000 365,000,000 106,675,000,000 69,040,000,000 37,581,000,000 13,006,000,000
Dec 2022 59,283,000,000 18,282,000,000 14,519,000,000 109,160,000,000 63,102,000,000 45,991,000,000 19,095,000,000

TTM Snapshot

Revenues TTM
$53,137,000,000
NetIncome TTM
$12,566,000,000
OpCashFlow TTM
$0
Assets (Latest)
$117,106,000,000
Forward EPS
$9.55

Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $85.00 · spot: $145.31 · call volume: 10,400 · put volume: 449
Expected Move to 2026-10-16: ±$7.01 (4.82%) — implied range $138.30 – $152.32 · ATM straddle on $145.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ABBV AbbVie Inc. $462.26B $261.59 —
NVS NOVARTIS AG $270.98B $142.57 —
NVSEF NOVARTIS AG $267.87B $140.93 —
AZN ASTRAZENECA PLC $250.42B $161.47 —
JNJ JOHNSON & JOHNSON $638.00B $264.74 —

News headlines (Yahoo Finance, 1h cache)

Why Merck (MRK) Dipped More Than Broader Market Today
2026-09-30 20:50 · Yahoo
Merck Says Investigational Skin Therapy Shows Potential
2026-09-30 18:29 · Yahoo
What Is Merck Stock's Biggest Opportunity?
2026-09-30 14:43 · Yahoo
Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline
2026-09-30 20:15 · Yahoo
After Moderna's Dizzying Rally, It's Time To Sell, Says Analyst
2026-09-30 20:11 · Yahoo
Moderna and Fair Isaac: The Best and Worst S&P 500 Stocks for the Third Quarter
2026-09-30 15:28 · Yahoo
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat
2026-09-30 13:42 · Yahoo
AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck
2026-09-29 20:55 · Yahoo
Citi delivers major verdict after Moderna’s remarkable 703% run
2026-09-30 22:17 · Yahoo
Top Analyst Reports for Apple, Microsoft & Broadcom
2026-09-30 19:20 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.